
Nutrimed Pharmaceuticals Private Limited
About Nutrimed Pharmaceuticals Private Limited
Data last updated:
Nutrimed Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U36990UP2010PTC040005. Its GSTIN is 09AADCN2448R1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Gautam Kumar Pandey and Sarita Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hn – 110 – C – Shri Ram Nagar Ganguli Tola Basharatpur, Gorakhpur, Uttar Pradesh, India – 273004.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.97 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹3,406 (net margin 0.3%) and EBITDA of ₹1.1 Lakh (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nutrimed Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHn – 110 – C – Shri Ram Nagar Ganguli Tola Basharatpur, Gorakhpur, Uttar Pradesh, India – 273004
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Nutrimed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nutrimed Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nutrimed Pharmaceuticals Private Limited, buy the company report.
Financials of Nutrimed Pharmaceuticals Private Limited
FY 2025 filings availableNutrimed Pharmaceuticals Private Limited reported revenue of ₹11.97 Lakh (up 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 77% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,406 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nutrimed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nutrimed Pharmaceuticals Private Limited
Nutrimed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gautam Kumar Pandey | Director | 26 Mar 2010 | 16 Years 7 Months | Current |
| Sarita Pandey | Director | 26 Mar 2010 | 16 Years 7 Months | Current |
Auditor
Nutrimed Pharmaceuticals Private Limited is audited by APNG & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APNG & ASSOCIATES | FY 2017 | 023338C |
Shareholding
The shareholding of Nutrimed Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nutrimed Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nutrimed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nutrimed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nutrimed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCN2448R1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nutrimed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nutrimed Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Gautam Kumar Pandey was appointed as Director on 26 Mar 2010.
Frequently asked questions
Nutrimed Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 March 2010 (16+ years old) and is registered under CIN U36990UP2010PTC040005.
Nutrimed Pharmaceuticals has 2 current directors:
- Gautam Kumar Pandey - Director
- Sarita Pandey - Director
The latest financial statements of Nutrimed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nutrimed Pharmaceuticals is 09AADCN2448R1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nutrimed Pharmaceuticals is U36990UP2010PTC040005. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nutrimed Pharmaceuticals was incorporated on 26 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Gautam Kumar Pandey was appointed as Director on 26 Mar 2010. Sarita Pandey was appointed as Director on 26 Mar 2010.
The registered office of Nutrimed Pharmaceuticals is at Hn – 110 – C – Shri Ram Nagar Ganguli Tola Basharatpur, Gorakhpur, Uttar Pradesh, India – 273004.
Nutrimed Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Nutrimed Pharmaceuticals is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.

